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Abstract
Oxytocin (OT) has been shownto be the dominantpeptideof the neurohypophysialfamilyexpressedby thymicepithelialand nurse
cells(TEC/TNC) invmiousspecies.Thymic OT is not secreted but, after translocation of a hybrid neurophysin/MHC class I protein,is
integratedwithinthe plasmamembraneof TEC, thus allowing its presentation to pre-T cells. In order to further demonstrate that thymic
OT behaves like a membrane antigen, we assessed the effect of rnAbs to OT on cytokine productions by cultures enriched in human TEC.
75–85% pure TEC cultures were prepared tlom human thymic fragments. Using immunofluorescence and confocal microscopy, ir-OT,
ir-interleukin-1~ (IL-1P), ir-interleukin-6 (IL-6) and ir-leukemia inhibitory factor (LIF) could be detected in these TEC cultures. ir-OT
was restricted to TEC, while some ir-IL-6 and ir-LIF were also seen in occasional fibroblasts. In basal conditions, ir-IL-6 and ir-LIF (but
not ir-OT and ir-IL-l@) were detected in the supematants of human TEC cultures. MAbs to OT induced a marked increase of ir-IL-6 and
ir-LIF secretion in TEC cultures. No significant effect was observed using mAbs against vasopressin, mouse immunoglobulins, or control
ascitic fluid controls. These data show that OT is fully processed and recognized by specific mAbs at the outer surface of TEC plasma
membrane. They further support that thymic OT behaves as the self-antigen of the nenrohypophysial family.
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1. Introduction
The epithelial component of thymic stroma plays an
important role in positive and negative selection of T
lymphocytes, [1–7]. The thymic repertoire of neuroen-
docrine-related polypeptide precursors has been proposed
to recapitulate at the molecular level the dual physiologic
role played by the thymus in T-cell development [8–10].
With a special regard to the neurohypophysial peptide
family, our group as well as others have shown that thymic
epithelial and nurse cells (TEC/TNC) synthesize oxytocin
(OT) and its precursor-associated protein, OT-neurophysin
[11,12]. Thymic OT plays a dual role in T-cell selection.
First, following its interaction with cognate receptors ex-
pressed on T cells [13,14], OT acts as a cryptocrine signal
involved in an accessory pathway of T-cell positive selec-
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tion [15,16]. Second, OT has been suggested to be the
prototype neurohypophysial self-antigen presented to im-
mature T cells by the thymic major histocompatibility
complex (MHO system.
Although ir-OT concentrations in the human thymus are
much higher than those of ir-vasopressin (VP), both neuro-
hypophysial (proOT and proVP) genes are transcribed in
the human and murine thymus [17,18]. Thymic OT is not
secreted but translocated in TEC plasma membrane in
association with a membranal 55-kDa neurophysin/MHC
class I hybrid protein [19]. A functional analogy was
observed in the binding and transport of OT between
neurophysin in the hypothalamo-neurohypophy sial axis [20]
and the neurophysin domain in the thymic microenviron-
ment. Presenting OT in such a manner to pre-T cells is
thought to lead to the central T-cell tolerance in neurohy-
pophysial family members [21]. This model of T-cell
education to the neurohypophysial self-antigen offers se-
lective advantages such as avoiding MHC class I allelic
0167-0115/96/$15.00 Copyright 01996 Elsevier Science B.V. All rights reserved.
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restriction and presenting the overall confirmational struc-
ture of the neurohypophysial peptide family.
TEC also express transcripts and proteins of various
cytokines, such as interleukin 1 (IL-1) [22], interleukin 6
(IL-6) and leukemia inhibitory factor (LIF) [23] which
were also found in the supernatants of TEC cultures. We
previously showed ir-IL-1(3to be colocated with ir-OT and
its neurophysin in thymic sections, more specifically in
TEC recognized with cytokeratin (CK) antibodies [24].
In the immune system, T-cell activation and cytokine
production usually follow the recognition and binding of
Abs to antigenic markers expressed on the surface of
T-cell membranes. In an attempt to unravel the physio-
logical significance of the colocalization of OT with other
polypeptides in TEC, we investigated the effect of anti-OT
monoclinal antibodies (mAbs) upon IL-1P, IL-6 and LIF
secretion by cultured human TEC cultures.
2. Material and methods
2.1. Antibodies
Anti-human cytokeratin mAb MNF 116 (lot 33) and
rabbit polyclonal Abs anti-cytokeratin A575 (lot 31D)
were obtained from Dako (Denmark). 033 and 013 are
anti-OT mAbs; 033 is directed against the cyclic part of
OT and 013 is directed against the C-terminal part of OT
[25]. BER 312 is an anti-VP mAb [26]. Anti-IL-6 mAb
(clone 4B2) was obtained from Medgenix Diagnostics
(Belgium). Anti-LIF is a specific antiserum kindly pro-
vided by A. Godard [27]. Second antibodies were fluores-
cein (FITC)-conjugated Affinipure goat anti-mouse IgG
(lot 28970), hereafter referred to as second antibody A;
FITC-conjugated Affinipure goat anti-mouse IgM (lot
17708), hereafter referred yo as second antibody B; and
rhodamine (TRITC)-conjugated Affinipure F(ab’)2 frag-
ment goat anti-rabbit IgG (H + L) (lot 27272), he=fter
referred as second antibody C. All conjugated Abs were
obtained from Jackson (Pennsylvania).
2.2, TEC cultures
Thymus fragments were obtained from children (6
months to 3 years old) undergoing corrective cardio-
vascular surgery for congenital cardiopathies. Surgical
fragments were pre-cut and washed by sedimentation at
1 X g, twice for 5 min in HBSS (Flow, 19-101-49), then
minced with scissors and washed again. The small frag-
ments ( <2 mm) were then transferred in Eagle’s mini-
mum essential medium containing D-VdiUe (Gibco) and
supplemented with 2 mmol/1 L-glutamine, 10 mmol/1
HEPES, 100 U/ml penicillin, 100 p,g/ml streptomycin
and 1096 heat-inactivated fetal calf serum (FCS; Gibco),
hereafter referred as complete TEC medium. D-Valine was
used to reduce the growth of fibroblasts [28,29]. Fragments
were then allowed to attach to T-75 flasks in the same
medium in a humidified atmosphere at 37°C and 5% C02,
and complete TEC medium was replaced every 3–4 days.
On day 17, the explants and adherent cells were detached
by treatment with Puck’s-modified solution containing
trypsin and EDTA (Gibco) and filtered through nylon gaze
to eliminate fragment residues. Cells were counted and
seeded at 6000 cells/well on 10 well/immunofluo-
rescence microplates, and at 50000 cells/well in 12-well
culture plates. The 10% FCS in complete medium was
replaced at this point by 1% Ultroser G-steroid free (Gibco),
hereafter designed as US-SF-TEC medium, for cytokine
assays. Ultroser G was used in order to avoid possible
artefacts reflecting the presence of cytokines in FCS, and
to further reduce fibroblast growth [30].
2.3. Immunojhorescence procedures
Immunofluorescence microplates were kept for three
days in FCS-TEC medium to allow plating of the TEC and
then stained for immunofluorescence after a 7-rein, –20°C
methanol fixation [24]. Plates were first incubated for 30
min at room temperature with 10Yonormal goat serum to
prevent non-specific binding of goat second antibody to
mouse or rabbit immunoglobulins. Single or double im-
munostaining was performed with the following reagents:
anti-human cytokeratins mAb MNF 116 diluted at 1:50
followed by second antibody A; anti-OT mAb 033, diluted
1:100 followed by second antibody B; anti-IL-6 mAb
diluted 1:10 followed by second mAb A diluted 1:40;
anti-LIF antiserum diluted 1:50, followed by second anti-
body C. In some experiments MNF 116 was replaced by
rabbit polyclonal anti-cytokeratin A575 diluted 1:200 fol-
lowed by second antibody C diluted 1:100. Extinction
controls were performed with second antibody alone, or
after the first non-related antibody. In the double immuno-
staining studies, the first step was always performed with
first mAb followed by the appropriate second antibody
prior to immunostaining with polyclonal antiserum. After
the final wash, the plates were mounted with
glycerol/gelatin medium.
2.4. Confocal microscopy
Immunostained cells were imaged using a Bio-Rad
MRC 100 laser scanning confocal unit mounted on an
Axiovert 135 Zeiss inverted microscope. Images were
collected with an 40 X objective (aperture 1.3, plan Neo-
fluar) or an oil immersion 63 X objective (aperture 1.4,
plan Apochromat). An Argon-Krypton ion laser source
was utilized for fluorescein (488 nm) and for rhodamine
(568 nrn). Kalman filtering was used to integrate the signal
collected over four frames to decrease the background
noise. Photographs were taken using a camera mounted on
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2.5. Cytokine assays
One ml of US-SF-TEC medium, with or without addi-
tives, was added on days 17, 21, 24 and 28 and super-
natants collected for assay on days 21, 24, 28 and 31. Each
experiment was repeated at least three times in duplicate.
Collected medium was stored at –20”C for cytokine
measurements. Additives were anti-OT IgM 033 ascitic
fluid, anti-OT IgG 013 ascitic fluid, anti-VP BER-312
ascitic fluid, mouse ascitic fluid depleted of IgG by three
fast-flow protein-A affinity absorption, and 5 mg/ml
mouse IgG (Sigma; lot 38F-8912), each at 1% (v/v).
Cytokine levels were measured using IL-1P, IL-6 and
LIF EASIAS (Medgenix Diagnostics) according to pub-
lished methods [31,32]
2.6. Statistical analyses
Values obtained from multiple experiments are reported
as percentage (%) of basal value at each time point.
Significance levels were determined by Mann-Whitney
U-test.
3. Results
3.1. Cytokeratin (CK), ir-OT, ir-LIF, ir-IL-6, ir-IL-lfi
immunojluorescence in hurnun TEC after 21-day culture
(Fig. 1)
A
The staining obtained with anti-CK mAb demonstrates
the dominant epithelial phenotype of cultured TEC. Count-
ing of mAb-stained cells versus total cultured cells showed
that 75–85% cells were authentic TEC (CK-positive) at
day 21, while 15–25% exhibited a fibroblast-like morphol-
ogy. All cultured cells were stained with anti-LIF anti-
serum, with a slightly different pattern according to the
cell of origin: bright filaments were stained in epithelial
cell, while a speckled and diffuse staining pattern was
observed in fibroblast-like cells (Fig. 1, first column).
Ir-OT was found in very close association with the CK
network. Epithelial cells appeared to be brightly stained
with anti-IL-6, while anti-IL-6 staining was weaker in
CK-negative cells (Fig. 1, second cohunn). Ir-IL-1~ was
also detected in the cytoplasm of cultured human TEC
associated with the major part of the CK network.
TEC and fibroblast-like cells were found to contain
both ir-IL-6 and ir-LIF, while ir-OT was almost exclu-
sively detected in epithelial (CK-positive) cells. Moreover,
the combined use of confocal microscopy and immuno-
fluorescence showed that anti-LIF and anti-OT outlined a
common filament network in epithelial cells, while LIF
immunoreactivity was much more less marked in fibrob-
last-like cells.
Fig. 2. Production of LIF and IL6 by human TEC: influence of mAb to
OT 013 and 033. TEC supematrmts tested for LIF (A) and IL6 (B)
content at time indicated, from day 21 to day 31. White columns are for
control culture, grey are for lYo033 added-culture and black are for lYo
013. Each column is the mean of quadmplicate measurements, with C.V.
less than 5%.
3.2. Production of IL-6 and LIF by human TEC: Influence
of mAbs to neurohypophysial peptides
IL-1P was not detected in our experimental conditions,
even in 5-fold concentrated medium, in either basal or
mAb-stimulated TEC supematants. As the detection limit
of the IL-1P EASIA is 50 pg/ml, IL-1P production by
50000 cultured TEC is under 10 pg/ml. On the other
hand, under basal conditions cultured TEC produce 500–
1000 pg\ml ir-LIF, as well as 6–40 rig/ml ir-IL-6. LIF
production showed a pronounced and sustained increase
over basal when anti-OT 033 and 013 mAbs were added
to TEC cultures (Fig. 2A). IL-6 production was sustained
by the addition of anti-OT mAbs, in contrast with the rapid
decrease under basal conditions (Fig. 2B).
3.3. Controls
LIF and IL-6 production by human TEC were not
affected by anti-VP mAb BER-312, by IgG-starved ascitic
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Fig. 3. Production of LIF and IL6 by human TEC: control experiments.
Only mAbs to OT (013 and 033) induced a marked increase of both LIF
(A) and IL6 (B) production by human TEC. Anti-VP mAb BER-312,
murine IgG, or murine ascitic fluid without IgG had no significant effect
upon IL6. Anti-VP induced a significant inhibition of IL6 production.
Each point is the mean of four experiments+ SD in triplicate. * P <0.001,
by Mann-Whitney U-test.
fluid, or by mouse IgG (Fig. 3A). In terms of IL-6
production, a slight but significant inhibitory effect of
anti-VP BER-312 was observed (Fig. 3B). There was no
significant difference between the positive effects of anti-
OT 013 and 033.
4. Discussion
The co-localization of ir-OT, IL-1~, IL-6 and LIF in
cultured human TEC has been shown by combined im-
munofluorescence and confocal microscopy. OT and LIF
staining in epithelial cells was closely related to the cytok-
eratin network on double immunofluorescence with anti-
cytokeratin MNF 116 mAb. This finding suggests that the
cytoskeleton of human TEC could be implicated in the
processes of membrane translocation and secretion for this
cell type. The results also are in close accord with previous
ultrastructural analyses showing ir-OT to be diffusely lo-
cated in the cytoplasm of murine TEC [12]. Cultured
human TEC thus express both OT and cytokirtes, and the
colocalization demonstrated confirms previous observa-
tions on human thymic sections [24]. Anti-OT staining of
cultured TEC adds further evidence that OT is the domi-
nant neurohypophysial-related peptide expressed in thymic
epitheliums.
A particular finding of the present study is that anti-OT
mAbs strongly stimulate LIF and IL-6 secretion by cul-
tured human TEC. The absence of EGF in US-SF might
explain why ir-IL-6 is below detection limits under basal
conditions, since biologically active and ir-IL-6 have been
detected in human TEC culture in EGF-supplemented
serum-free media, but not in DMEM or other EGF-defi-
cient media [33]. Moreover, this cytokine has been shown
to be regulated by EGF at a post-transcriptional level [34].
Colic et al reported IL-I(3 in the supematants from rat
TEC cultures [35], but Shoham et al found IL-1P below
detection limits in murine and human TEC cultures [36,37].
Thus, species differences or culture methods could explain
some of the discrepancies in the data previously reported.
The specificity of TEC activation by anti-OT mAbs has
been carefully established by a variety of control experi-
ments. It is not clearly due to a non-specific effect of Ig or
ascitic fluid, nor did the anti-VP mAb exert any significant
effect on LIF production, whereas it slightly inhibited
ir-IL-6 production. As OT and VP differ by only two
amino acids, the specific increase of cytokine production
by TEC upon antigen recognition confirms that OT is the
dominant self-antigen of the neurohypophysial family ex-
pressed by TEC. Both 033 and 013 stimulate cytokine
production by TEC, although 013 was previously shown
not to stain human thymic sections [24,38]. In processing
of the OT-precursor, OT must be cleaved from neuro-
physin before 9gly-OT amidation. The absence of TEC
labelling by 013 may thus reflect incomplete processing of
the OT precursor within the TEC cytoplasm. In contrast,
the biological effects observed with 013 argue for pre-
sentation of fully-processed OT at the level of the TEC
membranes.
The marked stimulating effect of artti-OT mAbs on
TEC cytokine production may be explained by induction
following immune recognition of the neurohypophysial-re-
lated antigen presented at the level of the TEC membrane.
Altogether, these data strongly support a membrane local-
ization of OT. The positive effects observed with two OT
mAbs directed against different epitopes of the OT
molecule strongly suggest that a fully processed OT is
presented at the TEC plasma membrane. Somehow like the
transduction following the binding of a signal to its recep-
tor, the immunological recognition of OT leads to TEC
activation reflected here by the secretion of IL-6 and LIF.
It will be also of interest to determine whether Abs against
other thymic self-antigens such as neurokinin A [39] and
insulin-like growth factor II [40,41] are also able to affect
TEC secretory activity. At the present stage, this study
supports our model on the dual physiological role played
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in T-cell differentiation by the thymic repertoire of neu-
roendocrine-related polypeptides [8,9].
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